Treatment of respiratory failure due to respiratory syncytial virus pneumonia with natural surfactant.
We describe two infants suffering from severe pneumonia caused by respiratory syncytial virus (RSV) infection and needing mechanical ventilation with both high ventilator settings and a high fraction of inspired oxygen. The severity of the respiratory failure and the possibility of decreased and/or altered surfactant production led us to treat these infants with intratracheal instillation of natural surfactant. This resulted in an improvement of lung compliance and a decrease in the amount of oxygen required to maintain acceptable oxygen saturations. Intratracheal surfactant instillation might, therefore, be useful in the treatment of severe RSV pneumonia.
Vos
G D
GD
Department of Pediatrics, University Hospital Maastricht, The Netherlands.
Rijtema
M N
MN
Blanco
C E
CE
D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011024:Pneumonia, Viral / Q000150:complications* / Q000628:therapy; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000627:therapeutic use*; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000209:etiology* / Q000628:therapy*; D018357:Respiratory Syncytial Virus Infections / Q000150:complications* / Q000628:therapy; D018113:Respiratory Syncytial Virus, Human
D011663:Pulmonary Surfactants